Amdocs Statistics
Amdocs (AOS) Stock Statistics & Valuation Metrics
Total Valuation
Amdocs has a market cap or net worth of EUR 4.03B. The enterprise value is EUR 6.86B.
- Market Cap
- EUR 4.03B
- Enterprise Value
- EUR 6.86B
Share Statistics
Amdocs has 107,571,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 107,571,000
- Owned by Insiders
- 0.17%
- Owned by Institutions
- 62.43%
Financial Efficiency
Amdocs’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 13.27%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 13.27%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 174.15K
- Profits Per Employee
- 18.59K
- Employee Count
- 26,969
- Asset Turnover
- 0.73
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Amdocs is 8.86. Amdocs’s PEG ratio is -1.13.
- PE Ratio
- 8.86
- PS Ratio
- 0.95
- PB Ratio
- 1.30
- Price to FCF
- 7.93
- Price to Operating Cash Flow
- 6.37
- PEG Ratio
- -1.13
Income Statement
In the last 12 months, Amdocs had revenue of 4.70B and earned 501.24M in profits. Earnings per share was 4.70.
- Revenue
- 4.70B
- Gross Profit
- 1.71B
- Operating Income
- 843.28M
- Pretax Income
- 635.77M
- Net Income
- 501.24M
- EBITDA
- 1.05B
- Earnings Per Share (EPS)
- 4.70
Cash Flow
In the last 12 months, operating cash flow was 672.72M and capital expenditures -110.53M, giving a free cash flow of 562.19M billion.
- Operating Cash Flow
- 672.72M
- Free Cash Flow
- 562.19M
- Free Cash Flow per Share
- 5.44
Dividends & Yields
Amdocs pays an annual dividend of ―, resulting in a dividend yield of 5.21%
- Dividend Per Share
- ―
- Dividend Yield
- 5.21%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 13.00%
- Earnings Yield
- 12.00%
Stock Price Statistics
- Beta
- 0.42
- 52-Week Price Change
- -47.72%
- 50-Day Moving Average
- 51.89
- 200-Day Moving Average
- 51.84
- Relative Strength Index (RSI)
- 31.12
- Average Volume (3m)
- 69
Important Dates
Amdocs upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 02, 2027
- Ex-Dividend Date
- ―
Financial Position
Amdocs as a current ratio of 0.94, with Debt / Equity ratio of 33.21%
- Current Ratio
- 0.94
- Quick Ratio
- 0.94
- Debt to Market Cap
- 0.16
- Net Debt to EBITDA
- 0.85
- Interest Coverage Ratio
- 17.87
Taxes
In the past 12 months, Amdocs has paid 134.53M in taxes.
- Income Tax
- 134.53M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Amdocs EV to EBITDA ratio is 5.96, with an EV/FCF ratio of 9.29.
- EV to Sales
- 1.11
- EV to EBITDA
- 5.96
- EV to Free Cash Flow
- 9.29
- EV to Operating Cash Flow
- 7.76
Balance Sheet
Amdocs has EUR 197.05M in cash and marketable securities with EUR 1.09B in debt, giving a net cash position of -EUR 896.36M billion.
- Cash & Marketable Securities
- EUR 197.05M
- Total Debt
- EUR 1.09B
- Net Cash
- -EUR 896.36M
- Net Cash Per Share
- -EUR 8.33
- Tangible Book Value Per Share
- EUR 0.89
Margins
Gross margin is 37.66%, with operating margin of 17.55%, and net profit margin of 10.61%.
- Gross Margin
- 37.66%
- Operating Margin
- 17.55%
- Pretax Margin
- 13.54%
- Net Profit Margin
- 10.61%
- EBITDA Margin
- 18.64%
- EBIT Margin
- 15.32%
Analyst Forecast
The average price target for Amdocs is EUR 41.03, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 41.03
- Price Target Upside
- 8.67% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- -1.54%
- EPS Growth Forecast
- -12.86%
Scores
- Smart Score
- 7
- AI Score
- ―
